Jennifer Smit to Contraceptive Agents, Female
This is a "connection" page, showing publications Jennifer Smit has written about Contraceptive Agents, Female.
Connection Strength
2,979
-
Contraceptive Continuation and Experiences Obtaining Implant and IUD Removal Among Women Randomized to Use Injectable Contraception, Levonorgestrel Implant, and Copper IUD in South Africa and Zambia. Stud Fam Plann. 2023 06; 54(2):379-401.
Score: 0,802
-
Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):363-5.
Score: 0,403
-
The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial. PLoS One. 2024; 19(8):e0307736.
Score: 0,223
-
Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS One. 2024; 19(3):e0295764.
Score: 0,217
-
Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval. Contraception. 2004 Jan; 69(1):3-7.
Score: 0,214
-
Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa. Soc Sci Med. 2002 Nov; 55(9):1511-22.
Score: 0,197
-
High HIV incidence among young women in South Africa: Data from a large prospective study. PLoS One. 2022; 17(6):e0269317.
Score: 0,191
-
Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa. Contraception. 2022 04; 108:37-43.
Score: 0,185
-
Women's contraceptive choice following the use of Implanon NXT: Findings from a study in Durban, South Africa. Afr J Reprod Health. 2021 Feb; 25(1):41-48.
Score: 0,175
-
Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant. Sex Transm Infect. 2021 06; 97(4):249-255.
Score: 0,172
-
Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception. S Afr Med J. 2011 Feb; 101(2):131-5.
Score: 0,087
-
Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception. Contraception. 2005 Mar; 71(3):170-5.
Score: 0,058
-
Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. PLoS One. 2024; 19(5):e0299802.
Score: 0,055